Regarding preexcitation syndromes, which ONE of the following statements is TRUE?
Answer: D: Tachycardia associated with Wolff-Parkinson-White syndrome (WPW) can be:
Verapamil, digoxin, adenosine and beta-blockers are only absolutely contraindicated in AF with preexcitation as they enhance conduction through the accessory pathway. The may also unmask a concealed pathway when given in SVT and WPW. Amiodarone and flecainide are the drugs of choice in AF with preexcitation, and cardioversion is required in unstable patients.
References:
Regarding reentrant SVT, which ONE of the following is TRUE?
Answer: D: Most (about 60%) of reentrant SVT have their reentry within the AV node as described in the previous question. About 20% have reentry involving a bypass tract (accessory pathway) and the remainder have reentry elsewhere
In WPW syndrome, 85% of reentrant SVT are orthodromic (pass through the AV node in the usual direction) and hence have a narrow QRS on ECG. Antidromic conduction will produce a broad complex QRS on the ECG.
Adenosine will revert about 90% of reentrant SVTs.
Reference:
Regarding WPW, all of the following statements are correct EXCEPT:
Answer: D: Only 1–2% of patients with WPW present with arrhythmias. The approximate breakdown of different types of arrhythmias in WPW are:
Characteristic ECG features of WPW are a triad of:
Additionally, WPW may also produce a tall R wave in V1, which may be misdiagnosed as a posterior myocardial infarction.
According to the Australian Resuscitation Council recommendations for management of AF, which ONE of the following is TRUE?
Answer: A: Amiodarone or digoxin are recommended as IV agents to control heart rate in the acute care setting in patients with AF and heart failure, who do not have an accessory pathway.
Dihydropyridine calcium channel blockers do not reduce heart rate (indeed, they may result in reflex tachycardia). Nondihydropyridine calcium channel blockers and beta-blockers are recommended in the acute care setting for rate control in AF, taking care in patients with hypotension and heart failure. Cardioversion is not recommended after 48 hours due to the increased risk of thromboembolism. Digoxin and nondihydropyridine sodium-channel blockers are contraindicated in preexcitation syndromes, where ventricular rate may be paradoxically accelerated.
With respect to AF in the ED, which ONE of the following is TRUE?
Answer. D: About 90% of ‘lone fibrillators’ will spontaneously revert with no treatment in the subsequent 48 hours. More than 60% of patents with AF will cardiovert with 100 J DC shock. When the patient is unstable due to rapid ventricular rate, immediate cardioversion should be attempted. It is important to exclude underlying illness, such as haemorrhage or sepsis, as the cause of the rapid ventricular rate prior to attempting cardioversion.
In the patient with chronic AF, rate control is the priority. Indeed, these patients carry a significant risk of embolic events if cardioverted without the necessary period of anticoagulation before and after cardioversion.